PolTREG signs agreement with Clinmark for clinical trials as part of diabetes treatment project
15:45
PolTREG has entered into an agreement worth around €5.3 million net with Clinmark to conduct Phase I/II clinical trials as part of the PreTREG diabetes treatment project, the company said.
PolTREG received PLN 31.7 million in funding from the Medical Research Agency for its priority project.
Source: ISB News
